Literature DB >> 21302042

Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence study.

Yun Li1, Mei-Juan Ding, Jing Ma, Shu Wang, Xiao-Li Wu, Hui-Juan Xu, Zheng-Yu Lu, Jian-Jun Zou, Hong-Wei Fan, Xue-Min Zhou.   

Abstract

A highly sensitive and rapid method for the analysis of pantoprazole in human plasma using liquid chromatography coupled to tandem electrospray ionization mass spectrometry was developed. The procedure involves a simple protein precipitation method with methyl alcohol and separation by RP-HPLC. Detection was performed by positive ion electrospray ionization in multiple reaction monitoring mode, monitoring the transitions m/z 384.1→200.0 and m/z 346.1→198.0, for quantification of pantoprazole and IS, respectively. The standard calibration curves showed good linearity within the range of 5-5,000 ng mL(-1). The lower limit of quantitation (LLOQ) was about 5 ng mL(-1). The extractive recovery of pantoprazole from the biological matrix was more than 77.58% and the matrix effect was complied with relevant provision. The intra-day accuracy of the drug containing serum samples was more than 92.19% with a precision of 0.79-5.36%. The inter-day accuracy was 85.49% or more, with a precision of 0.91-12.67%. Intra and inter-day accuracy of the assay at four concentrations were 97.9-98.2% with a precision of 4.2-13.9%. This method offered good precision and accuracy and was successfully applied to the pharmacokinetic and bioequivalence studies of 40 mg of enteric-coated pantoprazole in 20 healthy Chinese volunteers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21302042     DOI: 10.1007/s13318-010-0018-5

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  2 in total

1.  Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.

Authors:  Osmair Peres; Celso H Oliveira; Rafael E Barrientos-Astigarraga; Vinícius M Rezende; Gustavo D Mendes; Gilberto de Nucci
Journal:  Arzneimittelforschung       Date:  2004

2.  Bioequivalence study of two enteric-coated formulations of pantoprazole in healthy volunteers under fed conditions.

Authors:  Augusto Filipe; Susana Almeida; Ana Cristina Franco Spínola; Rita Neves; Fethi Trabelsi; Alex Torns; Eric Shink
Journal:  Arzneimittelforschung       Date:  2008
  2 in total
  3 in total

1.  Clopidogrel in Critically Ill Patients.

Authors:  Christian Schoergenhofer; Eva-Luise Hobl; Peter Schellongowski; Gottfried Heinz; Walter S Speidl; Jolanta M Siller-Matula; Monika Schmid; Raute Sunder-Plaßmann; Thomas Stimpfl; Matthias Hackl; Bernd Jilma
Journal:  Clin Pharmacol Ther       Date:  2017-11-03       Impact factor: 6.875

2.  Development and validation of a LC-MS/MS method for quantification of hetrombopag for pharmacokinetics study.

Authors:  Tao Chen; Zhonghua Chen; Suxing Zhang; Kezhi Zhang; Laiyou Wang
Journal:  Springerplus       Date:  2015-10-29

3.  Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography.

Authors:  Senthamil Selvan Perumal; Sanmuga Priya Ekambaram; Samundeswari Raja
Journal:  J Food Drug Anal       Date:  2014-10-28       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.